Home > Insider Trading > Filing (0000899243-23-005687)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1659352	Codiak Biosciences Inc.	CDAK	Biological Products, (No Disgnostic Substances) (2836)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1828153	Yalonda Howze	C/O Codiak Biosciences, Inc. 35 Cambridgepark Drive, Suite 500 Cambridge MA 02140	See Remarks	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2022-08-16	4,857	$0.00	7,345	No	4	M	Direct
Common Stock	Disposition	2022-08-17	1,512	$2.21	5,833	No	4	S	Direct
Common Stock	Acquisiton	2023-02-16	4,856	$0.00	10,689	No	4	M	Direct
Common Stock	Disposition	2023-02-17	1,603	$0.59	9,086	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Restricted Stock Units	Disposition	2022-08-16	4,857	$0.00	4,857	$0.00
Common Stock	Restricted Stock Units	Disposition	2023-02-16	4,856	$0.00	4,856	$0.00

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
14,568			No	4	M	Direct
9,712			No	4	M	Direct

Footnotes

Restricted stock units ("RSUs") convert into common stock on a one-for-one basis.
The sales reported in this Form 4 were effected to cover tax withholding obligations in connection with the vesting of RSUs pursuant to a "sell to cover" provision included in the RSU Agreement.
Each RSU represents a contingent right to receive one share of common stock.
On February 16, 2022, the reporting person was granted 19,425 RSUs, vesting in four equal installments every six months beginning on the six month anniversary of the grant date.